|
[1]XU J,LIU X,KOYAMA Y,et al.The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies[J].Front pharmacol,2014,5:167.
|
|
[2]XIN J,ZHANG X,CAO L,et al.The application of[18F]FDGRGD peptide in diagnosis of liver fibrosis[J].Prog Anat Sci,2015,21(3):245-248.(in Chinese)辛军,张新,曹礼,等.[18F]FDG-RGD多肽在肝纤维化诊断中的应用价值[J].解剖科学进展,2015,21(3):245-248.
|
|
[3]ZHANG X,XIN J,SHI Y,et al.Assessing activation of hepatic stellate cells by99mTc-3PRGD2 scintigraphy targeting integrinαvβ3:a feasibility study[J].Nucl Med Biol,2015,42(3):250-255.
|
|
[4]DU M,HAN TT,ZHANG X,et al.Evaluation of[11C]N-methyl acetazolamide PET/CT in early diagnosis of liver fibrosis4[J].J Chin Clin Med Imaging,2015,5(3):183-247.(in Chinese)杜名,韩婷婷,张新,等.[11C]N-甲基乙酰唑胺PET/CT评价肝脏纤维化早期诊断的价值[J].中国临床医学影像杂志,2015,5(3):183-247.
|
|
[5]HAN TT,DU M,ZHANG X,et al.Quantitative assessment of early liver fibrosis in rats using 13N-NH3·H2O PET/CT[J].Nucl Med Commun,2016,37(1):92-98.
|
|
[6]FRIEDMAN SL.Evolving challenges in hepaticfibrosis[J].Nat Rev Gastroenterol Hepatol,2010,7(8):425-436.
|
|
[7]WATSKY MA,WEBER KT,SUN Y,et al.New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies[J].Int Rev Cell Mol Biol,2010,282:165-192.
|
|
[8]GUO QL,WANG XZ.Role of liver sinusoidal endothelial cells in the formation of hepatic fibrosis[J].Chin Hepatol,2013,18(4):269-273.(in Chinese)郭杞兰,王小众.肝窦内皮细胞在肝纤维化形成中的作用[J].肝脏,2013,18(4):269-273.
|
|
[9]TANIGUCHI H,YAMAGUCHI A,KUNISHIMA S,et al.Using the spleen for time-delay correction of the input function in measuring hepatic blood flow with oxygen-15 water by dynamic PET[J].Ann Nucl Med,1999,13(4):215-221.
|
|
[10]ZHOU X,MURPHY FR,GEHDU N,et al.Engagement ofαvβ3 integrin regulates proliferation and apoptosis of hepatic stellate cells[J].J Bios Chem,2004,279(23):23996-24006.
|
|
[11]MA JX,YE DZ.Advances in tumor treatment with labeled somatostatin analogues[J].Foreign Med Sci:Radiol Nuclear Med,2005,29(2):79-84.(in Chinese)马寄晓,叶大铸.奥曲肽及其类似物用于肿瘤治疗的进展[J].国外医学:放射医学核医学分册,2005,29(2):79-84.
|
|
[12]RIEMANN D,HANSEN GH,NIELS-CHRISTIANSEN L,et al.Caveolae/lipid rafts in fibroblast-like synoviocytes:ectopeptidase-rich membrane microdomains[J].Biochem J,2001,354(Pt1):47-55.
|
|
[13]PATSENKER E,STICKEL F.Role of integrins in fibrosing liver diseases[J].Am J Physiol Gastrointest Liver Physiol,2011,301(3):g425-g434.
|
|
[14]LI F,SONG Z,LI Q,et al.Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrinαvβ3 expression with SPECT in rat[J].Hepatology,2011,54(3):1020-1030.
|
|
[15]AGRE P,SASAKI S,CHRISPEETS MJ.Aquaporins:a family of water channel proteins[J].Am J Physiol,1993,265(2):f461.
|
|
[16]CARRERAS FI,LEHMANN GL,FERRI D,et al.Defective hepatic aquaporim-8 expression and reduced canalicular membrane water permeability in estrogen-induced cholestasis[J].Am J Physiol Gastrointest Liver Physiol,2007,292(3):1554-1564.
|
|
[17]YOKOMORI H,ODA M,YOSHIMURA K,et al.Aquaporin-1associated with hepatic arterial capillary proliferation on hepatic sinusoid in human cirrhotic liver[J].Liver Int,2011,31(10):1554-1564.
|
|
[18]IGUCHI H,ODA M,YAMAZAKI H,et al.Aquaporin-1 is associated with arterial capillary proliferation and hepatic sinusoidal transformation contributing to potal hypertension in primary biliary cirrhosis[J].Med Mol Morphol,2014,47(2):90-99.
|
|
[19]ROBERT H,MEHER V,UDAY S,et al.Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis[J].Hepatology,2010,52(1):238-248.
|
|
[20]WANG F,FENG XC,LI YM,et al.Aqu aporins as potential drug targets[J].Acta Pharmacol Sin,2006,27(4):395-401.
|
|
[21]HATORI A,YUI J,XIE J,et al.Utility of translocator protein(18k Da)as a molecular imaging biomarker to monitor the progression of liver fibrosis[J].Sci Rep,2015,5:17327.
|
|
[22]KAO HW,CHEN CL,CHANG WY,et al.(18)F-FBHGal for asialoglycoprotein receptor imaging in a hepatic fibrosis mouse model[J].Bioorg Med Chem,2013,21(4):912-921.
|
|
[23]SCHUPPAN D,KIM YO.Evolving therapies for liver fibrosis[J].J Clin Invest,2013,123(5):1887-1901.
|
|
[24]WELLS RG.The portal fibroblast:notjust a poorman’s stellate cell[J].Gastroenterology,2014,147(1):41-47.
|
|
[25]DRANOFF JA,WELLS RG.Portal fibroblasts:underappreciated mediators of biliary fibrosis[J].Hepatology,2010,51(4):1438-1444.
|
|
[26]ARAP W,PASQUALINI R,RUOSLAHTI E.Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model[J].Science,1998,279(5349):377-380.
|
|
[27]COLOMBO G,CURMIS F,de MORI GMS,et al.Structure-activity relationships of linear and cyclic peptides containing the NGR tumor homing motif[J].J Biol Chem,2002,277(49):47891-47897.
|
DownLoad: